Initiating Joint Chinese-U.S. Activities on Biological Safety and Global Health Security
Center on Contemporary Conflict
MetadataShow full item record
China is critically important to international health and biological security efforts, yet awareness and implementation of biosafety and biosecurity practices are inconsistent among life science researchers and others working with pathogens and dual-use biotechnology in China. In late 2012, the Committee on International Security and Arms Control (CISAC) began development of a bilingual Chinese- English biotechnology and biosecurity glossary. This reference guide sought to map common conceptual understandings of biosecurity and the impact of biotechnology on biosafety and biosecurity, and to exchange information on U.S. and Chinese safety and security regulations for high-containment laboratories.
Performer: National Academy of Sciences (NAS) Principal Investigator: Benjamin J. Rusek Cost: $125,000 Fiscal Year(s): 2014-2015
RightsThis publication is a work of the U.S. Government as defined in Title 17, United States Code, Section 101. Copyright protection is not available for this work in the United States.
Showing items related by title, author, creator and subject.
Gronvall, Gigi Kwik; Ravi, Sanjana; Cicero, Anita; Inglesby, Tom (2014);Singapore is a critical security partner to the US in Southeast Asia. The US and Singapore share long-standing military relations, with American forces making use of Singapore’s Naval Base facilities, contributing to peace ...
Center on Contemporary Conflict; Rusek, Benjamin (Monterey, California: Naval Postgraduate School, 2016);This project will build on previous collaborative activities between NAS’s Committee on International Security and Arms Control and the Chinese Academy of Sciences on international global health security, biological ...
Center on Contemporary Conflict; Cicero, Anita (Monterey, California: Naval Postgraduate School, 2016);This follow-on project will comprise two biosecurity dialogues among the United States, Singapore, Malaysia, and Indonesia to address regional risks related to deliberate or accidental misuse of biological materials, ...